Neda Stjepanovic
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study design.
Journal: Future oncology (London, England)
Published: January 06, 2026
Early and continued asthma control up to week 24 in patients with severe, uncontrolled asthma treated with tezepelumab: Initial results of the real-world ASCENT study.
Journal: Respiratory medicine
Published: December 19, 2025
Early and continued asthma control up to week 24 in patients with severe, uncontrolled asthma treated with tezepelumab: Initial results of the real-world ASCENT study.
Journal: Respiratory medicine
Published: December 19, 2025
Efficacy of tezepelumab in patients with severe, uncontrolled asthma receiving high-dose inhaled corticosteroids in NAVIGATOR.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 10, 2025
Long-term Survival Analysis From PERLA, A Phase II Randomized Trial of Dostarlimab With Chemotherapy Versus Pembrolizumab With Chemotherapy in Metastatic Nonsquamous NSCLC.
Journal: JTO clinical and research reports
Published: August 11, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics.
Journal: American journal of respiratory and critical care medicine
Published: May 18, 2025
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data.
Journal: The journal of allergy and clinical immunology. In practice
Published: December 25, 2024
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress Update.
Journal: Tuberculosis and respiratory diseases
Published: December 23, 2024
Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy.
Journal: Clinical breast cancer
Published: July 05, 2024
Patient-reported outcomes in patients with metastatic non-squamous non-small cell lung cancer from the randomized Phase II PERLA trial comparing first-line chemotherapy plus dostarlimab or pembrolizumab.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 24, 2024
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial.
Journal: Nature communications
Published: March 03, 2023
Real-World Impact of Nonclinical Inhaler Regimen Switches on Asthma or COPD: A Systematic Review.
Journal: The journal of allergy and clinical immunology. In practice
Published: January 12, 2022
Last Updated: 09/26/2026